GL1X · GenesisL1 explorer

MolNFT v1 · #98007 · protein

M. tuberculosis DPRE1 in complex with inhibitor TCA1

4KW5 · Oxidoreductase: “M. tuberculosis DPRE1 in complex with inhibitor TCA1”. X-ray diffraction, 2 ligands (FAD, 1W6), 4 pockets (best druggability 0.81). MolNFT v1 #98007 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4KW5
Type
protein
Length
841 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Oxidoreductase
EC
1.1.98.3
UniProt
I6X8C4
Ligands
FAD, 1W6
Pockets
4 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 30% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AOxidoreductase (EC 1.1.98.3)protein42630% helix, 26% strandI6X8C4
BOxidoreductase (EC 1.1.98.3)protein41530% helix, 26% strandI6X8C4

Ligands and binding sites

  • FAD · Flavin-adenine dinucleotide · ligand · 2 copies · chains A, B
  • 1W6 · Ethyl ({2-[(1,3-benzothiazol-2-ylcarbonyl) amino]thiophen-3-yl}carbonyl)carbamate · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · 3 copies · chains A, B
  • IMD · Imidazole · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16020.810.8680FAD, 1W6
26340.790.8467FAD, 1W6
34470.570.7443empty
41470.400.7420empty

Interfaces

1 interface between chains.

  • A–B · 439 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 4KW5 · M. tuberculosis DprE1 in complex with inhibitor TCA1 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.